Jo J.A.M. Defauw

Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting

To investigate the effectiveness and safety of low-dose sotalol (a class III antiarrhythmic beta-blocking agent) in the prevention of supraventricular tachyarrhythmias (SVTs) and to identify predictors for the occurrence of these arrhythmias shortly after coronary artery bypass grafting, 300 consecutive patients were randomized in a double-blind, placebo-controlled fashion. Patients with severely depressed left ventricular function or other contraindications for beta blockers were excluded. Beginning at 4 hours and up to the sixth day after surgery, 150 patients received 40 mg of sotalol every 6 hours. SVT was observed in 24 (16%) of 150 low-dose sotalol-and in 49 (33%) of 150 placebo-treated patients [p less than 0.005]. In patients receiving sotalol, atrial fibrillation was the only noted tachyarrhythmia, whereas in the placebo group, 42 (28%) patients had atrial fibrillation, 3 (2%) atrial flutter, 1 (0.7%) atrial tachycardia and 3 (2%) sinus tachycardia. Drug-related adverse effects necessitating discontinuation of the drug were noted in only 2 (1%) sotalol-treated patients and 4 (3%) placebo-treated patients (p = not significant). For both groups, univariate analysis indicated that older age, 1- or 2-vessel coronary artery disease, long bypass (greater than or equal to 150 minutes) and aorta cross-clamp time (greater than or equal to 120 minutes) were predictive variables for the occurrence of SVTs. Multivariate analysis showed that male sex (odds ratio 2.3), 1- or 2-vessel coronary artery disease (odds ratio 2.0) and older age (odds ratio 1.1) were independent risk factors for increased occurrence of postoperative SVT.(ABSTRACT TRUNCATED AT 250 WORDS)

Risk of strut fracture of Björk-Shiley valves

The incidence of and factors that predispose to outlet strut fracture of Björk-Shiley heart valves are still not known. To obtain such information a retrospective cohort study was conducted on all 2303 patients in the Netherlands with a 60 degrees convexo-concave (60 degrees CC) or a 70 degrees convexo-concave (70 degrees CC) Björk-Shiley heart valve. Patients have been followed-up for a mean of 6.6 years (range 1-4271 days). 42 cases of mechanical failure due to outlet strut fracture have been recorded-6 of the 7 patients with fracture of the aortic valve died, as did 18 of the 35 patients with fracture of the mitral valve. Multivariate analysis identified wide opening angle (70 degrees), large valve size (greater than or equal to 29 mm diameter), and young age (less than 50 years) as risk factors for outlet strut fracture. For large 70 degrees CC mitral valves the cumulative risk of outlet strut fracture after 8 years was 17.4% (95% CI 9.1-31.6). Unlike previous findings, this excessive risk applied to late as well as to early batches of valves. In patients with a large 60 degrees CC mitral valve the cumulative risk after 8 years was 4.2% (95% CI 2.7-6.5). The incidence rate of outlet strut fracture in 60 degrees CC and 70 degrees CC valves (aortic and mitral) was constant over time. Overall survival since implantation was better for patients with 60 degrees CC prostheses than for those with 70 degrees CC prostheses; the adjusted hazard ratio for mortality for patients receiving a 70 degrees CC prosthesis was 1.5 (95% CI 1.1-2.0). Together with the low (24%) necropsy rate, this ratio suggests that the reported incidence of strut fracture for the 70 degrees CC valves is an underestimate. The data indicate that prophylactic replacement of 60 degrees CC and 70 degrees CC valves is advisable for selected groups of patients. Since the case-fatality rate is 50% for emergency replacement of faulty valves, patients suspected of Björk-Shiley heart-valve failure should be referred without delay to a cardiothoracic centre.

Mitral valve surgery and atrial fibrillation: is atrial fibrillation surgery also needed?

OBJECTIVE Atrial fibrillation (AF) persisting after mitral valve surgery reduces survival due to heart failure and thrombo-embolisms, and impairs quality of life. Arrhythmia surgery for AF shows today very satisfying results and therefore mitral valve surgery with AF surgery appears appealing. This study explores whether combined surgery in view of todays results of mitral valve surgery is indicated. METHODS AND RESULTS An outcome analysis of the arrhythmia outcome of patients undergoing exclusive mitral valve surgery with or without tricuspid repair was done. Preoperative baseline characteristics including arrhythmia pattern, surgical methods and follow-up findings were reviewed. Postoperative management of AF was not protocolized. Between 1990 and 1993, 162 consecutive patients underwent mitral valve surgery; follow-up was a mean of 3.3+/-1.9 years. In-hospital and late mortality were 1 and 9%, respectively. Sinus rhythm was preserved in 40 of 57 (70%) patients with preoperative sinus rhythm whereas AF persisted in 58 of 68 (85%) of patients with preoperative chronic AF (>1 year present). Sinus rhythm without AF was observed in 10 of 29 (34%) patients with preoperative paroxysmal AF. The 4-year Kaplan-Meier survival did not differ between patients with preoperative sinus rhythm (95.2%), paroxysmal AF (89.2%) and chronic AF (82.9%) but AF persisting after surgery tended to determine survival (P=0.05). Gender, age and right ventricular pressure and tricuspid valve repair were risk factors for postoperative recurrence of AF in patients with sinus rhythm at discharge, relative risk 0.35, 1.06, 1. 04 and 2.9, respectively. CONCLUSION Current mitral valve surgery with or without tricuspid valve repair does not eliminate preoperative paroxysmal or chronic AF. Secondly, because preoperative AF did not determine survival after mitral valve surgery, whereas postoperatively persisting AF was weakly associated with survival, atrial arrhythmia surgery primarily aims to reduce morbidity due to AF. Some characteristics can identify patients with increased propensity for persisting AF after surgery. Randomized studies of AF surgery are needed to identify suitable candidates for combined surgery.

Synchronous operation for ischemic cardiac and cerebrovascular disease: Early results and long-term follow-up

The late follow-up of 230 patients who underwent synchronous operation for extensive, obstructive extracranial and coronary artery disease from 1974 to 1989 was analyzed. Mean age at operation was 62.5 years; 161 patients (70%) were in New York Heart Association class III or IV, 185 (80%) had triple-vessel disease, and 67 (29%) had left main stem lesions of 50% or more. Previous myocardial infarctions were present in 132 patients (57%). Only 78 had normal left ventricular function. Included were 16 patients undergoing coronary reoperations, 17 patients with additional cardiac procedures, and 3 with synchronous pulmonary procedures. Symptomatic extracranial vascular disease or stabilized neurological deficits were present in 108 patients. Bilateral hemodynamically significant carotid disease was present in 91 patients and arch vessel lesions in 37. The hospital mortality in 8 patients (3.5%) was due to cardiac (n = 4), neurological (n = 1), or multiorgan failure (n = 3). Operative morbidity was mainly neurological (n = 20, 8.7%): 7 reversible deficits and 7 major strokes occurred, 2 reversible and 5 major strokes were related to the operated side(s), and 4 postoperative myocardial infarctions occurred. Actuarial survival at 5 years was 74% (+/- 3.3), at 10 years 54% (+/- 4.9), and at 15 years, 35% (+/- 6.6). This was mainly determined by late cardiac death (41/66). Late morbidity was mainly attributable to cardiac causes rather than neurological causes. At 5 and 10 years, respectively, 72% and 44% of the patients were free of major cardiac and neurological events or death. Synchronous revascularization can be performed relatively safely. The long-term outcome is determined by the extent and severity of the cardiovascular disease.

Dispersion of ‘Refractoriness’ in Noninfarcted Myocardium of Patients With Ventricular Tachycardia or Ventricular Fibrillation After Myocardial Infarction

BACKGROUND Postinfarction ventricular tachycardias (VTs) may degenerate into ventricular fibrillation (VF), but this does not happen in all patients. The underlying mechanism is not exactly known, but dispersion of refractory periods is considered a major factor in both induction and persistence of reentrant arrhythmias in general. Hypertrophied, noninfarcted myocardium has altered electrophysiological characteristics. We hypothesized that noninfarcted ventricular tissue may provide the heterogeneities that cause the transition from VT into VF. Local fibrillation intervals, ie, the average interval between local activations during VF, have previously been shown to correlate well with local refractoriness in human and canine atrium and in porcine and canine ventricle and may therefore be used as an index of local refractoriness. This technique permits simultaneous assessment of refractoriness at multiple sites. METHODS AND RESULTS We measured local fibrillation intervals at 32 to 64 sites in the noninfarcted part of the left ventricle in patients undergoing antiarrhythmic surgery for symptomatic, drug-refractory, postinfarction ventricular tachyarrhythmias. The grid of electrodes (interelectrode distance, 7 mm) was attached to the epicardium of the left ventricle remote from the infarcted tissue. Group 1 consisted of 7 patients with hemodynamically tolerable sustained VT (VT group). Group 2 consisted of 7 patients with cardiac arrest and documented VF (VF group). With the patients on cardiopulmonary bypass, VF was induced by multiple premature stimulation. The VF interval was not significantly different in the two study groups (VT group, 136 +/- 5.5 ms; VF group, 129 +/- 3.4 ms, mean +/- SEM). However, spatial dispersion of the VF intervals (remote from the infarcted area) expressed as the coefficient of variation of VF intervals (SD x 100/mean VF interval in each heart) was significantly larger in the VF group. It was 3.63 +/- 0.56 in the VF group and 1.55 +/- 0.40 in the VT group (mean +/- SEM; P < .01). Differences between the shortest and longest VF intervals in one and the same heart and the largest difference between two adjacent sites were also larger in the VF group (P < .02 and P < .05, respectively). CONCLUSIONS This study shows larger dispersion in VF intervals and therefore suggests larger dispersion of refractory periods in parts of the myocardium remote from the infarction in patients with postinfarction VF than in patients with postinfarction VT.

Use of Left Heart Bypass in the Surgical Repair of Thoracoabdominal Aortic Aneurysms

The purpose of this study was to assess the usefulness of left heart bypass in thoracoabdominal aortic aneurysm surgery. Data from 50 patients who underwent thoracoabdominal aortic aneurysm repair between July 1987 and October 1993 were retrospectively reviewed. In all of them a left heart bypass (left atrium to left femoral artery) with a centrifugal pump (without systemic heparinization) was used. Patient-, disease-, and operation-related variables were analyzed using univariate methods. There were no intraoperative deaths. The in-hospital mortality rate was 8% (n = 4). Survival rates were 77% (±6.5) at 2 years and 62% (±8.7) at 5 years. Renal failure requiring dialysis occurred in five (10%) patients and paraplegia in five (10%). Sixteen (32%) patients had respiratory insufficiency requiring prolonged (>8 days) ventilation. After univariate analysis, the risk factors for developing a need for postoperative dialysis were found to be the preoperative creatinine level (p = 0.002) and the presence of preoperative arterial hypertension (p=0.018). A history of peripheral vascular occlusive disease (p=0.008) was an important risk factor for predicting late death. No factors retained significance in the univariate analysis of hospital deaths and postoperative paraplegia. Renal and spinal ischemic times were substantially reduced in comparison to the theoretic times calculated if cross-clamping had been used. Bypass-related complications were completely absent. The use of a left heart bypass during thoracoabdominal aortic aneurysm surgery may not reduce the global complication rate; the results were similar to those achieved using simple cross-clamping. However, this technique appears to be the method of choice for protecting organ systems at risk during difficult repairs.

Slow potentials in the atrioventricular junctional area of patients operated on for atrioventricular node tachycardias and in isolated porcine hearts

OBJECTIVES The purpose of this study was to 1) investigate extracellular electrograms in the atrioventricular (AV) junctional area of patients with AV node reentrant tachycardia, 2) compare them with recordings made in isolated porcine hearts, and 3) study their origin. BACKGROUND Electrograms with slow components have been used to target the delivery of radiofrequency energy for the cure of AV node reentrant tachycardia. The origin of these electrograms is unknown. METHODS In 12 human and 19 porcine hearts, extracellular recordings were made simultaneously from 64 sites. In five other porcine hearts, intracellular recordings were made at sites at which extracellular electrograms revealed slow potentials. Histologic investigations were carried out in four of these hearts. RESULTS Electrograms with slow components were recorded in five human and eight porcine hearts. These signals were found at sites up to 12 mm from the His bundle. Characteristics of the electrograms did not differ significantly among human and porcine hearts. Electrophysiologic evidence for multiple pathways was present in four hearts. Superficial impalements with microelectrodes at sites with slow potentials showed action potentials with AV node characteristics. In the majority of these recordings, the upstroke coincided with the downstroke of slow potentials. Histologic investigations of the sites of impalement revealed transitional cells directly underneath the endocardium. CONCLUSIONS Slow potentials were recorded in both human and porcine hearts in similar measure. They arise from transitional cells and have action potentials similar to N cells.

Prophylactic Replacement Of BjÖrk-Shiley Convexo-Concave Valves At Risk Of Strut Fracture☆☆☆★★★

OBJECTIVE Prophylactic replacement of Björk-Shiley convexo-concave valves (Shiley, Inc., Irvine, Calif.) has been advised for selected groups of patients. If prophylactic replacement is considered, risks of postoperative morbidity and mortality have to be weighed against benefits of replacement. Here we report the results of prophylactic replacement of Björk-Shiley convexo-concave valves at risk of strut fracture in The Netherlands. METHODS We reviewed medical records of 36 patients undergoing prophylactic replacement of their Björk-Shiley convexo-concave valves before August 1995. Replacement was judged to be prophylactic if the risk of strut fracture outweighed that of death from reoperation, or the patient wished to have the valve replaced although it was not recommended. The procedure was also considered to be prophylactic if a concomitant pathologic condition, not likely to require cardiac surgery in the near future, was present or if preoperative examination revealed an unexpected cardiac pathologic condition. RESULTS Twenty-two 70-degree and 16 60-degree Björk-Shiley convexo-concave valves and one spherical valve were replaced (25 aortic and 14 mitral, including three double-valve replacements). Early mortality was 2.8% (1/36) (exact 95% confidence interval [CI] 0.1 to 14.5). Mean follow-up was 33 months. One- and 3-year survivals were 94% (95% CI 79% to 99%) and 91% (95% CI 74% to 97%), respectively. All three deaths were sudden. CONCLUSIONS If special care is taken in selecting patients, the risk of prophylactic replacement is comparable to that of primary valve replacement. More data are needed to assess whether the risk of sudden death is possibly increased.

Long-term survival after valve replacement with björk-shiley CC valves ∗

Abstract Information on the life expectancy of Bjork-Shiley convexo-concave (BScc) valve recipients is necessary when considering prophylactic replacement. However, little is known about the late results after valve replacement with BScc valves. We describe long-term survival and its determinants of the Dutch BScc cohort and compare mortality figures with those of the general population and those used in guidelines for prophylactic replacement. Follow-up was obtained on all Dutch BScc valve recipients (n = 2,264) (end of study 1996). Survival over a 15-year period and its determinants were described using the Kaplan-Meier product-limit method and Cox regression, respectively. Standardized mortality ratios (SMRs) were used to compare mortality rates of BScc valve recipients who survived at least 30 days after surgery with the Dutch population rates. Survival at 15 years for aortic, mitral, and double valve recipients was 55.0% (95% confidence interval [CI] 51.9 to 58.1), 40.8% (95% CI 37.1 to 44.4), and 38.6% (95% CI 33.2 to 43.9), respectively. The determinants of survival were patient, history, and procedure related. The SMR for all BScc valve recipients was 4.2 (95% CI 3.4 to 5.2) in the first year of follow-up, after which it decreased to 2.0 (95% CI 1.8 to 2.3) and remained constant until the 14th year. SMRs depended on time since implantation, age at the time of implantation, and position of the valve replaced. Most of life expectancy estimates in prophylactic replacement guidelines of BScc valves underrate the true survival estimates. Age, valve position, and time- specific risks of death after valvular surgery should be accounted for. Different excess mortality rates should be applied for patients from different age groups: the older the patient the lower the excess.

Epicardial Reflection as a Cause of Incessant Ventricular Bigeminy

Incessant monomorphic ventricular bigeminy was studied in a young patient with no organic heart disease. The arrhythmia could not be controlled by drug therapy. Spontaneous and artificial variation of the heart rate showed that reentry was the most likely arrhythmogenic mechanism. Peroperative epicardial and transmural mapping revealed an epicardial focal origin which was cryoablated. Reflected reentry occurring in a small area of working myocardial cells appeared to be the most likely explanation for this arrhythmia.